

Michael Fong
Asia-Pacific Operating Executive & Strategic Advisor
Technology · Healthcare · Interactive Entertainment
Building companies, commercializing complex technologies, and executing international growth across Asia and global markets.
Email:
Address:
Central, Hong Kong
25 Years Building What's Next
I am a Hong Kong-based executive and founder with more than 25 years of experience building and commercializing technology businesses across Asia-Pacific.
My career includes 16 years building Blizzard Entertainment’s Asia operations across 13 markets, managing a regional P&L exceeding US$500 million, and overseeing approximately 2,000 people across wholly owned operations and joint ventures.
I subsequently founded and exited a data-driven technology company in a highly regulated medical market. Today, I work with selected growth-stage technology and healthcare companies through PivotCXO and source and evaluate frontier-technology investments as a Venture Partner.
Strategy translated into operating execution.
CURRENT WORK
2023-Present
Founder & Operating Partner
(Hong Kong / Global)
PivotCXO
PivotCXO is the platform through which I undertake selected operating and strategic assignments for growth-stage and investor-backed technology and biotech companies.
I work directly with founders, management teams, boards, and investors on:
-
Corporate and growth strategy
-
International commercialization
-
Asia-Pacific market entry
-
Strategic partnerships
-
Organizational development
-
Financing and capital-event preparation
-
Commercial due diligence
-
Cross-border transactions
-
Embedded and fractional executive leadership
Nanyang Biologics - Strategic Advisor
Singapore
Nanyang Biologics is an AI-enabled drug-discovery company developing technology to support the identification and development of therapeutic candidates.
I advise management on corporate strategy, international expansion, strategic partnerships, organizational development, commercial positioning, and capital-markets preparation.
In October 2025, Nanyang Biologics announced a proposed business combination with RF Acquisition Corp II intended to result in a Nasdaq listing. The transaction gives Nanyang Biologics an approximate pre-transaction equity value of US$1.5 billion. (sec.gov)
My work focuses on helping the company translate its scientific and technology platform into a scalable international business.
Gominex - Strategic Advisor
China
Gominex develops brain-computer interface and AI-enabled technologies for mental health and related healthcare applications.
I advise the company on:
-
International commercialization
-
B2B and B2C channel strategy
-
Strategic partnerships
-
Corporate and organizational development
-
Financing preparation
-
Application of neuroscience and behavioural insights to product and commercial strategy
Interactive Entertainment Engagements — Strategic Advisor
Various
Advising selected game studios and digital platforms on corporate strategy, international market entry, publishing, strategic partnerships, commercialization, and fundraising.
Cross‑Border M&A – Lead
China/Germany
Led commercial due diligence and negotiations for the proposed acquisition of a German manufacturing company by a Chinese strategic buyer, coordinating deal evaluation and stakeholder alignment across jurisdictions.
2024-Present
Venture Partner
(San Francisco, United States)
VU Venture Partners
A global multi-stage deep-tech investment fund. I source and evaluate investment opportunities across frontier technology, artificial intelligence, healthcare, biotechnology, fintech, and deep technology.
My work includes:
-
Sourcing and screening prospective investments
-
Assessing markets, competition, and commercial potential
-
Evaluating business models and founder-market fit
-
Conducting commercial and financial due diligence
-
Presenting selected opportunities at partner meetings
-
Developing relationships with founders, co-investors, family offices, and institutional investors
Ongoing
Personal Investments
(Various)
SELECTED PERSONAL INVESTMENTS
Alongside my operating career, I invest personally in selected companies and investment vehicles across artificial intelligence, robotics, aerospace, neurotechnology, and healthcare.
These includes early investment exposure to OpenAI, SpaceX, Neuralink, Figure, and 1X Technologies.
- OPERATING TRACK RECORD -
2019-2023
(4 Years)
Founder & CEO
(Canada)
Confidential Tech Venture - Highly Regulated Medical Market
Founded, commercialized, and exited a data-driven technology company operating in a highly regulated medical market.
-
Built the company from concept through commercial launch
-
Led product development, regulatory navigation, finance, operations, and go-to-market execution
-
Developed the company’s technology-enabled operating and customer platform
-
Achieved a 2.6x multiple on invested capital within two years of commercial launch
-
Led the company through its acquisition in 2023
Company identity withheld in accordance with transaction confidentiality obligations.
ACQUIRED
2002-2018
(16 Years) (Hong Kong)
Founding Managing Director & Regional VP, Asia
Founding Managing Director - Greater China / Southeast Asia
Blizzard Entertainment
Joined Blizzard as a founding member of its Asia operation and spent 16 years building and scaling the regional business.
-
Built operations across 13 Asia-Pacific markets, including Greater China, South Korea, Japan, Taiwan, India, Australia, Singapore, and Southeast Asia
-
Managed a regional P&L exceeding US$500 million
-
Oversaw approximately 2,000 people across wholly owned operations and joint ventures
-
Established Blizzard’s initial offices in Greater China, Southeast Asia, Japan, and Australia
-
Negotiated major publishing, licensing, distribution, and strategic partnerships
-
Led the Asian commercialization of franchises including Warcraft, Diablo, StarCraft, Overwatch, and Hearthstone
2014-2017
Cooperative Activision Blizzard Int'l U.A.
(Amsterdam, Netherlands)
Managing Director & Board Member
1994-2002
(8 Years)
Director of Strategic Initiatives
(Hong Kong)
Core Financial Networks
Worked directly with the Vice Chairman of a Hong Kong-based family office on technology investments, portfolio-company strategy, fundraising, and strategic initiatives.
-
Sourced and evaluated startup and emerging-technology investments
-
Supported strategy and execution within selected portfolio companies
-
Led fundraising and investor-relations initiatives
-
Managed strategic projects involving investors, management teams, and portfolio-company stakeholders
EDUCATION
King's College London
Institute of Psychiatry, Psychology & Neuroscience (IoPPN)
Master of Science, Applied Neuroscience (In Progress)
Graduate study focused on cognition, brain function, mental health, human behaviour, neuroimaging, and neurotechnology.
Leicester Business School
Master of Business Administration
Strathclyde Business School
Master of Science, International Marketing
Cape Breton University
Bachelor of Arts, Psychology
- SELECT EXECUTIVE PROGRAMS -
Saïd Business School, University of Oxford
The Oxford Artificial Intelligence Programme
Stanford University Graduate School of Business
Digital Transformation & AI Playbook
Harvard Medical School
AI In Healthcare - From Strategy to Implementation
Columbia Business School
Corporate Governance
Venture University
Venture Capital Investor Accelerator Program
Singularity University
Exponential Technologies
UCLA Anderson School of Management
Strategic Thinking and Planning for Leaders
- CERTIFICATIONS -
The Council of Six Sigma Certification
Lean Six Sigma Black Belt
SKILLS

AI & Deep Technology Strategy
P&L Management — US$500M+
Cross-Border M&A
Strategic Partnerships & Deal-Making
Regional Organization Leadership — Approximately 2,000 People
Venture Capital & Due Diligence
Asia-Pacific Market Entry
Regulatory Navigation — Medical and Gaming
EXPERTISE
Asia Pacific Market Building
Built Blizzard's Asia business from zero to a $500M+ P&L across 13 markets — including Greater China, Japan, South Korea, Taiwan, and Southeast Asia. Knows what it actually takes to enter, scale, and sustain operations across the region's most complex markets.
Venture Capital & Deal Flow
Venture Partner at VU Venture Partners, sourcing and evaluating opportunities across AI, healthcare, biotechnology, fintech, and deep technology. Personal investor in selected frontier-technology companies and investment vehicles.
Founding & Exiting Ventures
Built Blizzard Entertainment’s Asia business and subsequently founded and exited a data-driven technology company in a highly regulated medical market, achieving a 2.6x multiple on invested capital within two years of commercial launch.
Capital Events & Transactions
Supporting growth-stage companies through financing, capital-markets preparation, commercial due diligence, and cross-border transactions, including advisory work for Nanyang Biologics following its announcement of a proposed US$1.5 billion business combination to pursue a Nasdaq listing.
AI Strategy & Application
Executive programmes at Oxford, Stanford GSB, and Harvard Medical School focused on AI strategy, deep tech, and AI in healthcare. Currently operating at the intersection of AI, drug discovery, and frontier capital markets.
Cross-Border Deal Execution
Extensive experience structuring and executing joint ventures, licensing agreements, acquisitions, and capital raises across Asia, North America, and Europe — navigating regulatory, cultural, and jurisdictional complexity at every stage.
Gaming & Interactive Entertainment
16 years at one of the world's most iconic gaming companies, including founding and scaling the entire Asia business to $500M+ P&L across 13 markets. An active resource for Web3 game platforms and game studios navigating strategy, market entry, and fundraising.
Applied Neuroscience & Human Behaviour
Currently completing an MSc in Applied Neuroscience at King’s College London’s Institute of Psychiatry, Psychology & Neuroscience. Applying graduate study in cognition, behaviour, mental health, and neurotechnology to business strategy, commercialization, and investment evaluation.
COMMUNITY

Rotary Club of Discovery Bay, Hong Kong
President Nominee · Chair of Service Projects
Serving Hong Kong communities through leadership, service, and civic engagement.